Lexology February 26, 2021
Reed Smith LLP

On February 24, 2021, President Biden signed an Executive Order (EO) that directs his administration to undertake a 100-day review of the supply chains of four key products: active pharmaceutical ingredients (APIs), critical minerals,1 semiconductors and advanced packaging, and large capacity batteries. The primary goal of this 100-day review is to identify actions that can be taken immediately to fix vulnerabilities in supply chains for these goods. Additionally, the EO calls for a more in-depth, one-year review of the supply chains of six key sectors: the defense industrial base, the public health and biological preparedness industrial base, the information and communications technology (ICT) industrial base, the energy sector industrial base, the transportation industrial base, and supply chains for agricultural commodities...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Provider, Public Health / COVID, Supply Chain, Technology
The AI Software Supply Chain Is A Dumpster Fire: Here's What Companies Can Do About It
Supply chain challenges in 2025: 5 things to know
As Supply Chains Go Digital, Cybersecurity Must be Strongest Link
Digital twins: The key to unlocking end-to-end supply chain growth
Why Supply Chain Technology Keeps Failing—And How To Fix It

Share This Article